Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DCVC Bio

Founders Anna Fokina John Hamer Kiersten Stead Matt Ocko Zachary Bogue

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 50
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 26
Rounds per year 8.33
Lead investments 13
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.48
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DCVC Bio:
Typical Co-investors
DCVC Bio is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DCVC Bio:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Asia Pacific Resources Development Investment China, Hong Kong, Hong Kong Island
BMO Harris Bank Chicago, Illinois, United States
Century Golden Resources Group Beijing, Beijing, China
Florac France, Ile-de-France, Paris
Hanhua Financial Holding Beijing, Beijing, China
Hanwha Investment Corp Seoul, Seoul-t'ukpyolsi, South Korea
HG Initiative -
Innovation Grade Capital -
Landstone Capital Beijing, Beijing, China
Microcap -
Picea Capital Germany, Hamburg
Raven Venture Partners Austin, Texas, United States
Scrum Software Fukuoka, Fukuoka Prefecture, Japan
TD Veen Norway, Rogaland, Stavanger
Treehouse Capital California, Oakland, United States
USAID East Africa Trade and Investment Hub -
Yipeng Zichan China, Jiading District
Yishi Medical Industry Investment Holdings Beijing, Beijing, China
Zhonghong Gold Control Beijing, Beijing Shi, China
ZopSmart Bangalore, India, Karnataka

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Latus Bio

$54M02 May 2024 -

Frontier Medicines

Artificial Intelligence
Biotechnology
Pharmaceutical
$80M22 Feb 2024 San Francisco, California, United States

Unlearn.AI

Artificial Intelligence
Bioinformatics
Biopharma
Clinical Trials
Life Science
Machine Learning
Software
$50M08 Feb 2024 San Francisco, California, United States

Elo Life Systems

Biotechnology
Health Care
Nutrition
Wellness
$20M24 Jan 2024 Durham, North Carolina, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M03 Jan 2024 California City, California, United States

Totus Medicines

Biopharma
Biotechnology
Medical
$66M15 Dec 2023 Cambridge, Massachusetts, United States

CH4 Global

Agriculture
Aquaculture
Biotechnology
$29M29 Aug 2023 Henderson, Nevada, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M14 Aug 2023 California City, California, United States

Solu Therapeutics

Biotechnology
Therapeutics
$31M01 Aug 2023 Boston, Massachusetts, United States
News
Stemson Therapeutics Raises $15M in Series A Funding

– Stemson Therapeutics, a San Diego-based company, closed a $15m Series A financing.
– The round was led by DCVC Bio with participation from Genoa Ventures, AbbVie Ventures and other investors.
– The company intends to use the funds to advance development of its proprietary therapeutic solution to cure hair loss.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DCVC Bio?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 50
Average round size 30M
Rounds per year 8.33
Peak activity year 2020
Lead investments 13
Follow on index 0.48
Exits 1
Group Appearance index 0.76

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Latus Bio

$54M02 May 2024 -

Frontier Medicines

Artificial Intelligence
Biotechnology
Pharmaceutical
$80M22 Feb 2024 San Francisco, California, United States

Unlearn.AI

Artificial Intelligence
Bioinformatics
Biopharma
Clinical Trials
Life Science
Machine Learning
Software
$50M08 Feb 2024 San Francisco, California, United States

Elo Life Systems

Biotechnology
Health Care
Nutrition
Wellness
$20M24 Jan 2024 Durham, North Carolina, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M03 Jan 2024 California City, California, United States

Totus Medicines

Biopharma
Biotechnology
Medical
$66M15 Dec 2023 Cambridge, Massachusetts, United States

CH4 Global

Agriculture
Aquaculture
Biotechnology
$29M29 Aug 2023 Henderson, Nevada, United States

Radionetics Oncology

Pharmaceutical
Therapeutics
$52M14 Aug 2023 California City, California, United States

Solu Therapeutics

Biotechnology
Therapeutics
$31M01 Aug 2023 Boston, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: